LMAT Lemaitre Vascular Inc

Price (delayed)

$51.4

Market cap

$1.13B

P/E Ratio

50.39

Dividend/share

$0.49

EPS

$1.02

Enterprise value

$1.13B

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, ...

Highlights
The equity has grown by 39% YoY
The company's gross profit rose by 7% YoY
LMAT's quick ratio has soared by 110% YoY but it is down by 18% QoQ
The company's debt has shrunk by 56% YoY but it rose by 11% QoQ
The P/E is 41% more than the 5-year quarterly average of 35.8 and 25% more than the last 4 quarters average of 40.2
The EPS has contracted by 28% YoY and by 19% from the previous quarter

Key stats

What are the main financial stats of LMAT
Market
Shares outstanding
21.96M
Market cap
$1.13B
Enterprise value
$1.13B
Valuations
Price to earnings (P/E)
50.39
Price to book (P/B)
4.37
Price to sales (P/S)
7.07
EV/EBIT
36.27
EV/EBITDA
27.01
EV/Sales
7.05
Earnings
Revenue
$159.54M
EBIT
$31.03M
EBITDA
$41.66M
Free cash flow
$29.16M
Per share
EPS
$1.02
Free cash flow per share
$1.33
Book value per share
$11.75
Revenue per share
$7.27
TBVPS
$8.37
Balance sheet
Total assets
$299.43M
Total liabilities
$41.39M
Debt
$17.21M
Equity
$258.03M
Working capital
$125.08M
Liquidity
Debt to equity
0.07
Current ratio
6.34
Quick ratio
4.15
Net debt/EBITDA
-0.09
Margins
EBITDA margin
26.1%
Gross margin
65.6%
Net margin
13.9%
Operating margin
19.5%
Efficiency
Return on assets
7.6%
Return on equity
8.7%
Return on invested capital
20.2%
Return on capital employed
11.2%
Return on sales
19.4%
Dividend
Dividend yield
0.94%
DPS
$0.49
Payout ratio
47.5%

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
0.92%
1 week
4.03%
1 month
4.75%
1 year
-4.6%
YTD
2.33%
QTD
12.84%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$159.54M
Gross profit
$104.59M
Operating income
$31.09M
Net income
$22.23M
Gross margin
65.6%
Net margin
13.9%
The company's net margin fell by 27% YoY and by 19% QoQ
The company's operating margin fell by 24% YoY and by 15% QoQ
LMAT's net income is down by 23% year-on-year and by 18% since the previous quarter
The operating income has contracted by 19% YoY and by 15% from the previous quarter

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
P/E
50.39
P/B
4.37
P/S
7.07
EV/EBIT
36.27
EV/EBITDA
27.01
EV/Sales
7.05
The P/E is 41% more than the 5-year quarterly average of 35.8 and 25% more than the last 4 quarters average of 40.2
The EPS has contracted by 28% YoY and by 19% from the previous quarter
The equity has grown by 39% YoY
LMAT's price to book (P/B) is 9% lower than its 5-year quarterly average of 4.8 but 4% higher than its last 4 quarters average of 4.2
The P/S is 14% above the 5-year quarterly average of 6.2 and 4% above the last 4 quarters average of 6.8
Lemaitre Vascular's revenue has increased by 6% YoY

Efficiency

How efficient is Lemaitre Vascular business performance
The ROE has contracted by 47% YoY and by 24% from the previous quarter
Lemaitre Vascular's return on assets has decreased by 33% YoY and by 21% QoQ
LMAT's ROIC is down by 32% year-on-year and by 20% since the previous quarter
The ROS has contracted by 24% YoY and by 16% from the previous quarter

Dividends

What is LMAT's dividend history
DPS
$0.49
Dividend yield
0.94%
Payout ratio
47.5%
Recent dividends

Financial health

How did Lemaitre Vascular financials performed over time
LMAT's quick ratio has soared by 110% YoY but it is down by 18% QoQ
Lemaitre Vascular's current ratio has soared by 51% YoY but it has decreased by 18% from the previous quarter
The company's debt is 93% lower than its equity
Lemaitre Vascular's debt to equity has shrunk by 67% YoY but it has increased by 17% QoQ
The company's debt has shrunk by 56% YoY but it rose by 11% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.